Thomas Kromann Lund

879 total citations
43 papers, 542 citations indexed

About

Thomas Kromann Lund is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Physiology. According to data from OpenAlex, Thomas Kromann Lund has authored 43 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 14 papers in Surgery and 9 papers in Physiology. Recurrent topics in Thomas Kromann Lund's work include Transplantation: Methods and Outcomes (12 papers), Asthma and respiratory diseases (9 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers). Thomas Kromann Lund is often cited by papers focused on Transplantation: Methods and Outcomes (12 papers), Asthma and respiratory diseases (9 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers). Thomas Kromann Lund collaborates with scholars based in Denmark, United Kingdom and Norway. Thomas Kromann Lund's co-authors include Lars Pedersen, Vibeke Backer, Celeste Porsbjerg, Hendrik Nolte, Simon Francis Thomsen, Peter J. Barnes, Sergei A. Kharitonov, B. Larsson, Michael Perch and V. Backer and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Allergy and Clinical Immunology.

In The Last Decade

Thomas Kromann Lund

37 papers receiving 526 citations

Peers

Countries citing papers authored by Thomas Kromann Lund

Since Specialization

Citations

This map shows the geographic impact of Thomas Kromann Lund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Kromann Lund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Kromann Lund more than expected).

Fields of papers citing papers by Thomas Kromann Lund

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Kromann Lund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Kromann Lund. The network helps show where Thomas Kromann Lund may publish in the future.

Co-authorship network of co-authors of Thomas Kromann Lund

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Kromann Lund. A scholar is included among the top collaborators of Thomas Kromann Lund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Kromann Lund. Thomas Kromann Lund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Allogeneic mesenchymal stromal cell therapy on primary graft dysfunction after lung transplantation 2025 ·JHLT Open ·Abbas Ali Qayyum, Thomas Kromann Lund, (unknown), (unknown), Mandana Haack‐Sørensen, Annette Ekblond, (unknown), Hasse Møller‐Sørensen, Anders Bruun Mathiasen, Christian H. Møller, Sara Rørvig, (unknown), Helle Brüünsgaard, Thomas Litman, Ellen Mønsted Johansen, (unknown), Jens Kastrup, Michael Perch	1
2	Relation of pulmonary diffusing capacity changes to HRCT chest and V/Q SPECT findings at short-term and intermediate follow-up after COVID-19: a prospective cohort study (The secure study) 2025 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), (unknown), Jan Christensen, Thomas Kromann Lund, (unknown), Frederikke F. Rönsholt, (unknown), (unknown), Anne‐Mette Lebech, Ronan M. G. Berg, Terese L. Katzenstein, Jann Mortensen	0
3	Extracellular vesicles in lung donor plasma: Potential indicators of donor organ quality 2025 ·Journal of Thoracic and Cardiovascular Surgery ·(unknown), Kishor Dhaygude, R. Krebs, (unknown), Maija Puhka, Saara Laitinen, Göran Dellgren, Jesper Magnusson, Erik Holmberg, (unknown), Thomas Kromann Lund, (unknown), Peter Raivio, Ilkka Helanterä, Fredrik Åberg, S. Syrjälä, Antti I. Nykänen, Karl Lemström	0
4	Trends in underlying causes of death in allogeneic hematopoietic cell transplant recipients over the last decade 2024 ·European Journal Of Haematology ·(unknown), Joanne Reekie, Henrik Sengeløv, Caspar da Cunha‐Bang, Thomas Kromann Lund, (unknown), (unknown), (unknown), (unknown), Jens Lundgren, (unknown)	7
5	Machine learning identifies remodeling patterns in human lung extracellular matrix 2024 ·Acta Biomaterialia ·Monica Jane Emerson, (unknown), Chris D. Madsen, Raphael Reuten, (unknown), Thomas Kromann Lund, Anders Bjorholm Dahl, T. Jensen, Janine T. Erler, Alejandro E. Mayorca‐Guiliani	0
6	Anemia in liver transplant recipients: prevalence, severity, risk factors, and survival 2023 ·Apmis ·(unknown), Omid Rezahosseini, (unknown), Dina Leth Møller, (unknown), (unknown), (unknown), Jens Hillingsø, Thomas Kromann Lund, Allan Rasmussen, Susanne Dam Nielsen	0
7	Renin–angiotensin–system inhibitors and the risk of exacerbations in chronic obstructive pulmonary disease: a nationwide registry study 2023 ·BMJ Open Respiratory Research ·(unknown), (unknown), (unknown), (unknown), Tor Biering‐Sørensen, Rikke Sørensen, (unknown), Ole Hilberg, Lars Pedersen, Thomas Kromann Lund, Tobias Wirenfeldt Klausen, Kristoffer Grundtvig Skaarup, Josefin Eklöf, Pradeesh Sivapalan, Jens‐Ulrik Stæhr Jensen	2
8	Effect of once-per-day tacrolimus versus twice-per-day ciclosporin on 3-year incidence of chronic lung allograft dysfunction after lung transplantation in Scandinavia (ScanCLAD): a multicentre randomised controlled trial 2023 ·The Lancet Respiratory Medicine ·Göran Dellgren, Thomas Kromann Lund, Peter Raivio, (unknown), (unknown), Erik Holmberg, Peter Skov Olsen, Maija Halme, Arnt E. Fiane, Sandra Lindstedt, Gerdt C. Riise, Jesper Magnusson	18
9	Post-Transplantation Anemia and Risk of Death Following Lung Transplantation 2022 ·Transplantation Proceedings ·(unknown), Michael Perch, Omid Rezahosseini, C. Crone, (unknown), Hans Henrik Lawaetz Schultz, (unknown), Mads Hornum, Susanne Dam Nielsen, Thomas Kromann Lund	4
10	Trends in underlying causes of death in solid organ transplant recipients between 2010 and 2020: Using the CLASS method for determining specific causes of death 2022 ·PLoS ONE ·(unknown), Joanne Reekie, Allan Rasmussen, Caspar da Cunha‐Bang, Finn Gustafsson, Kasper Rossing, Michael Perch, (unknown), Søren Schwartz Sørensen, Thomas Kromann Lund, Vibeke Rømming Sørensen, (unknown), (unknown), (unknown), (unknown), Jens Lundgren, Nicholas J. Wareham	14
11	First patient with ILNEB syndrome due to pathogenic variants in ITGA3 surviving to adulthood 2021 ·European Journal of Medical Genetics ·(unknown), Stephen D. Marks, Jakob Ek, Frederik Buchvald, Thomas Kromann Lund, Michael Perch, Aoife Waters, Mette Mogensen, Anne Marie Jelsig	4
12	Bacterial Re-Colonization Occurs Early after Lung Transplantation in Cystic Fibrosis Patients 2021 ·Journal of Clinical Medicine ·(unknown), Hans Henrik Lawaetz Schultz, Helle Krogh Johansen, T. Pressler, Thomas Kromann Lund, Martin Iversen, Michael Perch	22
13	Lung Ultrasound to Phenotype Chronic Lung Allograft Dysfunction in Lung Transplant Recipients. A Prospective Observational Study 2021 ·Journal of Clinical Medicine ·Jesper Rømhild Davidsen, Christian B. Laursen, Mikkel Højlund, Thomas Kromann Lund, Klaus Nielsen, Martin Iversen, (unknown), Elisabeth Bendstrup, Jørn Carlsen, Michael Perch, Daniel Pilsgaard Henriksen, Hans Henrik Lawaetz Schultz	6
14	Design and Rationale of a Scandinavian Multicenter Randomized Study Evaluating if Once-Daily Tacrolimus Versus Twice-Daily Cyclosporine Reduces the 3-year Incidence of Chronic Lung Allograft Dysfunction After Lung Transplantation (ScanCLAD Study) 2020 ·Advances in Therapy ·Göran Dellgren, Thomas Kromann Lund, Peter Raivio, (unknown), (unknown), Jesper Magnusson, Gerdt C. Riise	5
15	Blood and Urinary Concentrations of Salbutamol in Asthmatic Subjects 2010 ·Medicine & Science in Sports & Exercise ·(unknown), Lars Pedersen, (unknown), Thomas Kromann Lund, Peter Hemmersbach, Kim Dalhoff, Vibeke Backer	24
16	Are asthma-like symptoms in elite athletes associated with classical features of asthma? 2009 ·British Journal of Sports Medicine ·Thomas Kromann Lund, Lars Pedersen, Sandra D. Anderson, Asger Sverrild, V. Backer	23
17	Inflammatory Subtypes in Asthma are Related to Airway Hyperresponsiveness to Mannitol and Exhaled NO 2009 ·Journal of Asthma ·Celeste Porsbjerg, Thomas Kromann Lund, Lars Pedersen, Vibeke Backer	83
18	Asthma in elite athletes: how do we manage asthma‐like symptoms and asthma in elite athletes? 2009 ·The Clinical Respiratory Journal ·Thomas Kromann Lund	5
19	Prevalence of asthma‐like symptoms, asthma and its treatment in elite athletes 2009 ·Scandinavian Journal of Medicine and Science in Sports ·Thomas Kromann Lund, Lars Pedersen, B. Larsson, Vibeke Backer	32
20	Pharmaceutical treatment of asthma symptoms in elite athletes – doping or therapy? 2007 ·Scandinavian Journal of Medicine and Science in Sports ·Vibeke Backer, Thomas Kromann Lund, Lars Pedersen	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact